Skip to main content
. 2022 Sep 6;10(9):1481. doi: 10.3390/vaccines10091481

Table 1.

Clinical and Hospitalization Data according to Vaccine Status.

Vaccinated (n = 109) Non-Vaccinated (n = 92) p-Value
Female (n, %) 67 (61.5%) 43 (46.75%) 0.159
Age (years) * 65.0 ± 21.0 46.5 ± 16.0 <0.001
Weight (kg) 77.7 ± 13.5 76.6 ± 13.9 0.557
Height (cm) 164.8 ± 8.6 167.5 ± 9.2 0.304
Previous Medical Co-morbidities
Number of pre-existing co-morbidities * 1.7 ± 1.0 0.85 ± 0.95 <0.001
Obesity (pre-existing) 33 (30.3%) 20 (21.7%) 0.240
Hypertension (pre-existing) 51 (46.8%) 21 (22.8%) 0.318
Diabetes (pre-existing) 23 (21.1%) 5 (5.4%) 0.212
Asthma (pre-existing) 12 (11.0%) 7 (7.6%) 0.434
COPD (pre-existing) * 10 (9.2%) 2 (2.2%) 0.04
Pain (pre-existing) * 51 (46.8%) 26 (28.25%) 0.03
Cardiac diseases (pre-existing) * 21 (19.3%) 6 (6.5%) 0.01
Rheumatological diseases (pre-existing) * 29 (26.6%) 6 (6.5%) <0.001
Other diseases (pre-existing) 22 (20.2%) 13 (14.1%) 0.305
COVID-19 associated-onset symptoms at hospital admission
Number of COVID-19 symptoms 2.4 ± 0.9 2.65 ± 0.65 0.677
Fever (COVID-19 onset) 70 (64.2%) 60 (65.2%) 0.930
Dyspnea (COVID-19 onset) 22 (20.2%) 27 (29.35%) 0.189
Myalgias (COVID-19 onset) 39 (35.8%) 29 (31.5%) 0.605
Cough (COVID-19 onset) 37 (33.9%) 30 (32.6%) 0.870
Headache (COVID-19 onset) 40 (36.7%) 26 (28.25%) 0.298
Diarrhea (COVID-19 onset) 4 (3.7%) 13 (14.1%) 0.708
Anosmia (COVID-19 onset) 15 (13.8%) 14 (15.2%) 0.786
Ageusia (COVID-19 onset) * 11 (10.1%) 21 (22.8%) 0.02
Throat pain (COVID-19 onset) 15 (13.8%) 17 (18.5%) 0.404
Vomiting (COVID-19 onset) 1 (0.9%) 2 (2.2%) 0.467
Dizziness (COVID-19 onset) 5 (4.6%) 6 (6.5%) 0.559
Days at hospital * 12.9 ± 12.45 9.7 ± 7.8 0.03
ICU admission 11 (10.1%) 8 (8.7%) 0.748

* Significant differences between vaccinated and non-vaccinated groups (p < 0.05).